Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease

American Journal of Human Genetics

Volumn 91, Issue 1, 2012, Pages 152-162

  Tang, Weihong ^a   Schwienbacher, Christine ^b,c   Lopez, Lorna M ^d   Ben Shlomo, Yoav ^e   Oudot Mellakh, Tiphaine ^f   Johnson, Andrew D ^g,h   Samani, Nilesh J ^i,j   Basu, Saonli ^a   Gögele, Martin ^b   Davies, Gail ^d   Lowe, Gordon D O ^k   Tregouet, David Alexandre ^f   Tan, Adrian ^a   Pankow, James S ^a   Tenesa, Albert ^l,m   Levy, Daniel ^h   Volpato, Claudia B ^b   Rumley, Ann ^k   Gow, Alan J ^d   Minelli, Cosetta ^b   Yarnell, John W G ⁿ   Porteous, David J ^d   Starr, John M ^d   Gallacher, John ^o   Boerwinkle, Eric ^p   Visscher, Peter M ^q   Pramstaller, Peter P ^b,r,s   Cushman, Mary ^t   Emilsson, Valur ^u   Plump, Andrew S ^u   Matijevic, Nena ^p   Morange, Pierre Emmanuel ^v   Deary, Ian J ^d   Hicks, Andrew A ^b   Folsom, Aaron R ^a   more..

^a UNIVERSITY OF MINNESOTA   (United States)

^b University of Lubeck   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f INSERM   (France)

^g FRAMINGHAM HEART STUDY   (United States)

^h NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

ⁱ UNIVERSITY OF LEICESTER   (United Kingdom)

^j GLENFIELD HOSPITAL   (United Kingdom)

^k UNIVERSITY OF GLASGOW   (United Kingdom)

^l UNIVERSITY OF EDINBURGH   (United Kingdom)

^m UNIVERSITY OF EDINBURGH   (United Kingdom)

ⁿ QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^o CARDIFF UNIVERSITY   (United Kingdom)

^p UNIVERSITY OF TEXAS   (United States)

^q QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^r General Central Hospital   (Italy)

^s UNIVERSITY OF LÜBECK   (Germany)

^t UNIVERSITY OF VERMONT   (United States)

^u MERCK RESEARCH LABORATORIES   (United States)

^v AIX MARSEILLE UNIVERSITY   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HISTIDINE; LOW MOLECULAR WEIGHT KININOGEN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD GROUP ABO SYSTEM; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA ANALYSIS; DATA BASE; EUROPE; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME;

COHORT STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTHROMBIN TIME; RISK; THROMBOEMBOLISM; THROMBOSIS;

EID: 84863985392     PISSN: 00029297     EISSN: 15376605     Source Type: Journal    
DOI: 10.1016/j.ajhg.2012.05.009     Document Type: Article

References (57)

1. G.C. White 2nd The partial thromboplastin time: defining an era in coagulation J. Thromb. Haemost. 1 2003 2267 2270
2. S. Kitchen, A. McCraw, and M. Echenagucia Diagnosis of Hemophilia and Other Bleeding Disorders: A Laboratory Manual 2nd ed. 2010 World Federation of Hemophilia (WFH) Montreal
3. D.S. Jacobs Laboratory test handbook 2001 Lexi-Comp Hudson, Ohio
4. G. Hron, S. Eichinger, A. Weltermann, P. Quehenberger, W.M. Halbmayer, and P.A. Kyrle Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time J. Thromb. Haemost. 4 2006 752 756
5. N.A. Zakai, T. Ohira, R. White, A.R. Folsom, and M. Cushman Activated partial thromboplastin time and risk of future venous thromboembolism Am. J. Med. 121 2008 231 238
6. A.P. Owens 3rd, and N. Mackman Tissue factor and thrombosis: The clot starts here Thromb. Haemost. 104 2010 432 439
7. J.C. Souto, L. Almasy, M. Borrell, M. Garí, E. Martínez, J. Mateo, W.H. Stone, J. Blangero, and J. Fontcuberta Genetic determinants of hemostasis phenotypes in Spanish families Circulation 101 2000 1546 1551
8. D.M. Warren, J.M. Soria, J.C. Souto, A. Comuzzie, J. Fontcuberta, J. Blangero, J.W. MacCluer, and L. Almasy Heritability of hemostasis phenotypes and their correlation with type 2 diabetes status in Mexican Americans Hum. Biol. 77 2005 1 15
9. J.C. Souto, L. Almasy, M. Borrell, F. Blanco-Vaca, J. Mateo, J.M. Soria, I. Coll, R. Felices, W. Stone, J. Fontcuberta, and J. Blangero Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia Am. J. Hum. Genet. 67 2000 1452 1459
10. L.M. Houlihan, G. Davies, A. Tenesa, S.E. Harris, M. Luciano, A.J. Gow, K.A. McGhee, D.C. Liewald, D.J. Porteous, and J.M. Starr Common variants of large effect in F12, KNG1, and HRG are associated with activated partial thromboplastin time Am. J. Hum. Genet. 86 2010 626 631
11. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators Am. J. Epidemiol. 129 1989 687 702
12. C. Pattaro, F. Marroni, A. Riegler, D. Mascalzoni, I. Pichler, C.B. Volpato, U. Dal Cero, A. De Grandi, C. Egger, and A. Eisendle The genetic study of three population microisolates in South Tyrol (MICROS): study design and epidemiological perspectives BMC Med. Genet. 8 2007 29
13. I.J. Deary, A.J. Gow, M.D. Taylor, J. Corley, C. Brett, V. Wilson, H. Campbell, L.J. Whalley, P.M. Visscher, D.J. Porteous, and J.M. Starr The Lothian Birth Cohort 1936: a study to examine influences on cognitive ageing from age 11 to age 70 and beyond BMC Geriatr. 7 2007 28
14. J.W. Yarnell, P.M. Sweetnam, A. Rumley, and G.D. Lowe Lifestyle factors and coagulation activation markers: the Caerphilly Study Blood Coagul. Fibrinolysis 12 2001 721 728
15. Y. Li, C. Willer, S. Sanna, and G. Abecasis Genotype imputation Annu. Rev. Genomics Hum. Genet. 10 2009 387 406
16. Y. Li, C.J. Willer, J. Ding, P. Scheet, and G.R. Abecasis MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes Genet. Epidemiol. 34 2010 816 834
17. W.M. Chen, and G.R. Abecasis Family-based association tests for genomewide association scans Am. J. Hum. Genet. 81 2007 913 926
18. Y.S. Aulchenko, S. Ripke, A. Isaacs, and C.M. van Duijn GenABEL: an R library for genome-wide association analysis Bioinformatics 23 2007 1294 1296
19. S. Purcell, B. Neale, K. Todd-Brown, L. Thomas, M.A. Ferreira, D. Bender, J. Maller, P. Sklar, P.I. de Bakker, M.J. Daly, and P.C. Sham PLINK: a tool set for whole-genome association and population-based linkage analyses Am. J. Hum. Genet. 81 2007 559 575
20. C.J. Willer, Y. Li, and G.R. Abecasis METAL: fast and efficient meta-analysis of genomewide association scans Bioinformatics 26 2010 2190 2191
21. P.E. Morange, T. Oudot-Mellakh, W. Cohen, M. Germain, N. Saut, G. Antoni, M.C. Alessi, M. Bertrand, A.M. Dupuy, and L. Letenneur KNG1 Ile581Thr and susceptibility to venous thrombosis Blood 117 2011 3692 3694
22. V. Fourel, J.M. Gabastou, F. Desroys du Roure, N. Ehrhardt, and A. Robert Influence of age, sex and ABO blood group on activated partial thromboplastin time Haemostasis 23 1993 321 326
23. J.C. Souto, L. Almasy, E. Muñiz-Diaz, J.M. Soria, M. Borrell, L. Bayén, J. Mateo, P. Madoz, W. Stone, J. Blangero, and J. Fontcuberta Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time Arterioscler. Thromb. Vasc. Biol. 20 2000 2024 2028
24. D. Scanavini, D. Girelli, B. Lunghi, N. Martinelli, C. Legnani, M. Pinotti, G. Palareti, and F. Bernardi Modulation of factor V levels in plasma by polymorphisms in the C2 domain Arterioscler. Thromb. Vasc. Biol. 24 2004 200 206
25. L.J. Jensen, M. Kuhn, M. Stark, S. Chaffron, C. Creevey, J. Muller, T. Doerks, P. Julien, A. Roth, and M. Simonovic STRING 8 - a global view on proteins and their functional interactions in 630 organisms Nucleic Acids Res. 37 Database issue 2009 D412 D416
26. J.Z. Liu, A.F. McRae, D.R. Nyholt, S.E. Medland, N.R. Wray, K.M. Brown, N.K. Hayward, G.W. Montgomery, P.M. Visscher, N.G. Martin, S. Macgregor AMFS Investigators A versatile gene-based test for genome-wide association studies Am. J. Hum. Genet. 87 2010 139 145
27. G.A. Ewald, and P.R. Eisenberg Plasmin-mediated activation of contact system in response to pharmacological thrombolysis Circulation 91 1995 28 36
28. A. Murphy, J.H. Chu, M. Xu, V.J. Carey, R. Lazarus, A. Liu, S.J. Szefler, R. Strunk, K. Demuth, and M. Castro Mapping of numerous disease-associated expression polymorphisms in primary peripheral blood CD4+ lymphocytes Hum. Mol. Genet. 19 2010 4745 4757
29. T. Zeller, P. Wild, S. Szymczak, M. Rotival, A. Schillert, R. Castagne, S. Maouche, M. Germain, K. Lackner, and H. Rossmann Genetics and beyond - the transcriptome of human monocytes and disease susceptibility PLoS ONE 5 2010 e10693
30. R.S. Fehrmann, R.C. Jansen, J.H. Veldink, H.J. Westra, D. Arends, M.J. Bonder, J. Fu, P. Deelen, H.J. Groen, and A. Smolonska Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA PLoS Genet. 7 2011 e1002197
31. D.M. Greenawalt, R. Dobrin, E. Chudin, I.J. Hatoum, C. Suver, J. Beaulaurier, B. Zhang, V. Castro, J. Zhu, and S.K. Sieberts A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort Genome Res. 21 2011 1008 1016
32. E.E. Schadt, C. Molony, E. Chudin, K. Hao, X. Yang, P.Y. Lum, A. Kasarskis, B. Zhang, S. Wang, and C. Suver Mapping the genetic architecture of gene expression in human liver PLoS Biol. 6 2008 e107
33. F. Innocenti, G.M. Cooper, I.B. Stanaway, E.R. Gamazon, J.D. Smith, S. Mirkov, J. Ramirez, W. Liu, Y.S. Lin, and C. Moloney Identification, replication, and functional fine-mapping of expression quantitative trait loci in primary human liver tissue PLoS Genet. 7 2011 e1002078
34. H. Schunkert, I.R. König, S. Kathiresan, M.P. Reilly, T.L. Assimes, H. Holm, M. Preuss, A.F. Stewart, M. Barbalic, C. Gieger Cardiogenics CARDIoGRAM Consortium Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease Nat. Genet. 43 2011 333 338
35. M. Preuss, I.R. König, J.R. Thompson, J. Erdmann, D. Absher, T.L. Assimes, S. Blankenberg, E. Boerwinkle, L. Chen, L.A. Cupples CARDIoGRAM Consortium Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls Circ Cardiovasc Genet. 3 2010 475 483
36. I.D. Bezemer, L.A. Bare, C.J. Doggen, A.R. Arellano, C. Tong, C.M. Rowland, J. Catanese, B.A. Young, P.H. Reitsma, J.J. Devlin, and F.R. Rosendaal Gene variants associated with deep vein thrombosis JAMA 299 2008 1306 1314
37. Y. Li, I.D. Bezemer, C.M. Rowland, C.H. Tong, A.R. Arellano, J.J. Catanese, J.J. Devlin, P.H. Reitsma, L.A. Bare, and F.R. Rosendaal Genetic variants associated with deep vein thrombosis: the F11 locus J. Thromb. Haemost. 7 2009 1802 1808
38. N.L. Smith, L.A. Hindorff, S.R. Heckbert, R.N. Lemaitre, K.D. Marciante, K. Rice, T. Lumley, J.C. Bis, K.L. Wiggins, F.R. Rosendaal, and B.M. Psaty Association of genetic variations with nonfatal venous thrombosis in postmenopausal women JAMA 297 2007 489 498
39. P. Greenwell Blood group antigens: molecules seeking a function? Glycoconj. J. 14 1997 159 173
40. E. Hosoi Biological and clinical aspects of ABO blood group system J. Med. Invest. 55 2008 174 182
41. V.M. Morelli, M.C. de Visser, N.H. van Tilburg, H.L. Vos, J.C. Eikenboom, F.R. Rosendaal, and R.M. Bertina ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens Thromb. Haemost. 97 2007 534 541
42. D.A. Trégouët, S. Heath, N. Saut, C. Biron-Andreani, J.F. Schved, G. Pernod, P. Galan, L. Drouet, D. Zelenika, and I. Juhan-Vague Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach Blood 113 2009 5298 5303
43. I.M. Sainz, R.A. Pixley, and R.W. Colman Fifty years of research on the plasma kallikrein-kinin system: from protein structure and function to cell biology and in-vivo pathophysiology Thromb. Haemost. 98 2007 77 83
44. A.L. Jones, M.D. Hulett, and C.R. Parish Histidine-rich glycoprotein: A novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems Immunol. Cell Biol. 83 2005 106 118
45. T. Shigekiyo, H. Yoshida, Y. Kanagawa, K. Satoh, S. Wakabayashi, T. Matsumoto, and T. Koide Histidine-rich glycoprotein (HRG) Tokushima 2: novel HRG deficiency, molecular and cellular characterization Thromb. Haemost. 84 2000 675 679
46. T. Shigekiyo, H. Yoshida, K. Matsumoto, H. Azuma, S. Wakabayashi, S. Saito, K. Fujikawa, and T. Koide HRG Tokushima: molecular and cellular characterization of histidine-rich glycoprotein (HRG) deficiency Blood 91 1998 128 133
47. N. Tsuchida-Straeten, S. Ensslen, C. Schäfer, M. Wöltje, B. Denecke, M. Moser, S. Gräber, S. Wakabayashi, T. Koide, and W. Jahnen-Dechent Enhanced blood coagulation and fibrinolysis in mice lacking histidine-rich glycoprotein (HRG) J. Thromb. Haemost. 3 2005 865 872
48. C. Lee, E. Bongcam-Rudloff, C. Sollner, W. Jahnen-Dechent, and L. Claesson-Welsh Type 3 cystatins; fetuins, kininogen and histidine-rich glycoprotein Front. Biosci. 14 2009 2911 2922
49. N.L. Smith, M.H. Chen, A. Dehghan, D.P. Strachan, S. Basu, N. Soranzo, C. Hayward, I. Rudan, M. Sabater-Lleal, J.C. Bis Wellcome Trust Case Control Consortium Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium Circulation 121 2010 1382 1392
50. H. Ireland, C.J. Konstantoulas, J.A. Cooper, E. Hawe, S.E. Humphries, H. Mather, A.H. Goodall, J. Hogwood, I. Juhan-Vague, and J.S. Yudkin EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro Atherosclerosis 183 2005 283 292
51. A.P. Reiner, C.L. Carty, N.S. Jenny, C. Nievergelt, M. Cushman, D.J. Stearns-Kurosawa, S. Kurosawa, L.H. Kuller, and L.A. Lange PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health Study J. Thromb. Haemost. 6 2008 1625 1632
52. H.A. Ireland, J.A. Cooper, F. Drenos, J. Acharya, J.P. Mitchell, K.A. Bauer, J.H. Morrissey, M.P. Esnouf, and S.E. Humphries FVII, FVIIa, and downstream markers of extrinsic pathway activation differ by EPCR Ser219Gly variant in healthy men Arterioscler. Thromb. Vasc. Biol. 29 2009 1968 1974
53. W. Tang, S. Basu, X. Kong, J.S. Pankow, N. Aleksic, A. Tan, M. Cushman, E. Boerwinkle, and A.R. Folsom Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study Blood 116 2010 5032 5036
54. S. Ghosh, U.R. Pendurthi, A. Steinoe, C.T. Esmon, and L.V. Rao Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium J. Biol. Chem. 282 2007 11849 11857
55. J. López-Sagaseta, R. Montes, C. Puy, N. Díez, K. Fukudome, and J. Hermida Binding of factor VIIa to the endothelial cell protein C receptor reduces its coagulant activity J. Thromb. Haemost. 5 2007 1817 1824
56. C.J. Jackson, and M. Xue Activated protein C - an anticoagulant that does more than stop clots Int. J. Biochem. Cell Biol. 40 2008 2692 2697
57. V. Gandin, A. Miluzio, A.M. Barbieri, A. Beugnet, H. Kiyokawa, P.C. Marchisio, and S. Biffo Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation Nature 455 2008 684 688